BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b2497 (Published 19 June 2009) Cite this as: BMJ 2009;338:b2497
  1. John Frew, specialist registrar,
  2. Clive Peedell, consultant clinical oncologist,
  3. Sath Gokul, consultant medical oncologist
  1. 1James Cook University Hospital, Middlesbrough TS4 3BW
  1. johnfrew{at}doctors.org.uk

    A 76 year old woman with metastatic adenocarcinoma of the lung started treatment with the epidermal growth factor receptor (EGFR) inhibitor …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription